NaderN.HannaMDFACS, FSSO
General Surgery • Philadelphia, PAColon & Rectal Surgery, Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)
Chief of Surgical Oncology, Jefferson Health
Dr. Hanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1025 Walnut Street
Suite 607B
Philadelphia, PA 19107Phone+1 215-503-2498Fax+1 215-503-8505
Education & Training
University of ChicagoFellowship, Complex General Surgical Oncology, 1994 - 1997
St Elizabeth's Medical CenterResidency, Surgery, 1989 - 1994
Waltham Weston Hospital Medical CenterInternship, Transitional Year, 1988 - 1989
Ain Shams University Faculty of MedicineClass of 1985
Certifications & Licensure
MD State Medical License 2004 - 2026
NJ State Medical License 2024 - 2025
PA State Medical License 2024 - 2024
KY State Medical License 1998 - 2006
MA State Medical License 1993 - 2005
IL State Medical License 1994 - 2002- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors for Cancer Castle Connolly, 2009-2015
- Top Doctors:Baltimore Area Castle Connolly, 2012-2013, 2015
- Top Doctors (Top 1%) US News & World report, 2012
- Join now to see all
Clinical Trials
- Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer Start of enrollment: 2009 Aug 01
- Borderline Pancreas Study: FOLFIRINOX +SBRT Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.Paloma Moreno, Yuuki Ohara, Amanda J Craig, Huaitian Liu, Shouhui Yang
Carcinogenesis. 2024-11-22 - 1 citationsMIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways.Shouhui Yang, Wei Tang, Azadeh Azizian, Jochen Gaedcke, Yuuki Ohara
Carcinogenesis. 2024-08-12 - ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer.Yuuki Ohara, Huaitian Liu, Amanda J Craig, Shouhui Yang, Paloma Moreno
International Journal of Cancer. 2024-08-01
Professional Memberships
- Member
- Member
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
